Please go to ENTER SURVEY to give us your feedback on Ursula Theuretzbacher‘s talk “Redeveloping Old Antibiotics for Use: European Initiative." Registration is open for the Oct 13 B2DG event with Caleb Bell. Register now at .

The Bio2Device Group (B2DG) is a premier organization for all San Francisco Bay Area professionals in pharmaceutical, biotech, medical device, diagnostics and other life science industry sectors. Weekly programs are designed to keep members up-to-date with industry news, help them explore other industry sectors, and provide networking opportunities with other life science professionals from all industry sectors and corporate functions. The B2DG also hosts a moderated LinkedIn Group to facilitate communication between members.

Our Next Event

Caleb B. Bell III - CEO - Bell Biosystems
10/13/2015 - 6:00pm
Wilson Sonsini Goodrich & Rosati- 650 Page Mill Road, Palo Alto, CA

Bell Biosystems was founded around a core discovery of a new synthetic biology tool that adds functionality to cells; this platform was identified by the White House through a competitive process as one of the five most “revolutionary life science platform technologies” in 2014. Bell is currently in beta testing of their Magnelle® cell tracking solution for preclinical tracking and control of...

Syndicate content